Please login to the form below
anaesthetics
This page shows the latest anaesthetics news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
Acacia finally gets FDA okay for first product Barhemsys
Meanwhile, the UK company is also preparing for a possible approval by 5 April of ByFavo (remimazolam), an ultra-short-acting and reversible intravenous benzodiazepine sedative/anaesthetic for use during procedural
-
Sandoz expands into Japan with €400m Aspen deal
Aspen’s portfolio consists of approximately 20 off-patent medicines, including anaesthetics like Xylocaine and speciality brands such as immune suppressing drug Imuran for multiple sclerosis patients.
-
Stung by critics, J&J says antidepressant Spravato saves money
It is a single isomer form of ketamine, a low-cost anaesthetic, and ICER says the similarity between the two drugs “raises issues for all stakeholders about how to consider
-
J&J’s Spravato breaks depression drought at FDA
The green light for nasal spray formulation of esketamine – a derivative of the anaesthetic ketamine – is for use of the drug as an add-on to oral antidepressants in people with
-
Gyroscope's gene therapy given to first dry AMD patient
GT005 was administered under a local anaesthetic by Robert MacLaren, an ophthalmology specialist at Oxford Eye Hospital.
Acacia finally gets FDA okay for first product Barhemsys
Sandoz expands into Japan with €400m Aspen deal
Stung by critics, J&J says antidepressant Spravato saves money
J&J’s Spravato breaks depression drought at FDA
Gyroscope's gene therapy given to first dry AMD patient
More from news
Approximately 1 fully matching, plus 28 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2016
200+. Janssen / J&J (US). Piramal (IN). Asset acquisition. 5 injectable pain / anaesthetic products.
-
Deal Watch September 2016
500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva, Nimbex, Tracrium, Mivacron and Anectinein – excludes US/CA rights].
-
Deal Watch June 2016
Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
-
Pharma deals in June 2015
Neosaxitoxin, novel anaesthetic for local anaesthesia and post-op pain management. Collaboration, licence.
-
Pharma deals during March 2014
Baxter's medical products business has annual sales of over $9bn and a portfolio of intravenous solutions and nutritional therapies, drug delivery systems, premixed and other injectable drugs, inhalation anaesthetics and
Deal Watch October 2016
Pharma deals during March 2014
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Greener healthcare - a shared challenge
Hospitals have also been exploring retrofitting heat recovery technology to dialysis machines, and switching operating room anaesthetics (which account for almost a third of the UK’s health and social care
-
Addressing Climate Impact: The Healthcare Paradox
Similarly, some procedures are particularly carbon intensive. Hospitals have been exploring solutions ranging from retrofitting heat recovery technology to dialysis machines, to switching operating room anaesthetics, which account for almost a
-
It’s all about patient outcomes… right?
general anaesthetic. ... Routledge; London, UK, 2002. Snow SJ. Blessed Days of Anaesthesia: How Anaesthetics Changed the World.
-
"Legal highs" ruling leaves illegal labs laughing
These include the anaesthetic nitrous oxide, or laughing gas. . N2O has been used as a recreational drug since 1799, when 'laughing gas parties' were popular among the ruling classes.
-
Healthcare 2025: what the future holds for pharma
This was led by major advances in three core areas:. Health: Access to innovative medicines, surgery and anaesthetics, clean air and water.
Greener healthcare - a shared challenge
Addressing Climate Impact: The Healthcare Paradox
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- Embattled Biogen talks up Aduhelm
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- New data from Moderna supports COVID boosters
- $47.5m research centre to seek genetic insights into disease
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Nicky Hutchens appointed as deputy managing director at Four Health
- Health For All
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
No results were found
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
